858 related articles for article (PubMed ID: 32414838)
1. Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2.
McCormick-Baw C; Morgan K; Gaffney D; Cazares Y; Jaworski K; Byrd A; Molberg K; Cavuoti D
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32414838
[No Abstract] [Full Text] [Related]
2. Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2.
Williams E; Bond K; Zhang B; Putland M; Williamson DA
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32317257
[No Abstract] [Full Text] [Related]
3. Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays.
Moran A; Beavis KG; Matushek SM; Ciaglia C; Francois N; Tesic V; Love N
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32303565
[No Abstract] [Full Text] [Related]
4. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Oropharyngeal Swab Specimens.
Hou H; Chen J; Wang Y; Lu Y; Zhu Y; Zhang B; Wang F; Mao L; Tang YW; Hu B; Ren Y; Sun Z
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32503847
[No Abstract] [Full Text] [Related]
5. Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.
Basu A; Zinger T; Inglima K; Woo KM; Atie O; Yurasits L; See B; Aguero-Rosenfeld ME
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32471894
[TBL] [Abstract][Full Text] [Related]
6. Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges.
Broder K; Babiker A; Myers C; White T; Jones H; Cardella J; Burd EM; Hill CE; Kraft CS
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32444354
[No Abstract] [Full Text] [Related]
7. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test.
Loeffelholz MJ; Alland D; Butler-Wu SM; Pandey U; Perno CF; Nava A; Carroll KC; Mostafa H; Davies E; McEwan A; Rakeman JL; Fowler RC; Pawlotsky JM; Fourati S; Banik S; Banada PP; Swaminathan S; Chakravorty S; Kwiatkowski RW; Chu VC; Kop J; Gaur R; Sin MLY; Nguyen D; Singh S; Zhang N; Persing DH
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32366669
[TBL] [Abstract][Full Text] [Related]
8. Evaluation on testing of deep throat saliva and lower respiratory tract specimens with Xpert Xpress SARS-CoV-2 assay.
Wong RC; Wong AH; Ho YI; Leung EC; Lai RW
J Clin Virol; 2020 Oct; 131():104593. PubMed ID: 32823131
[TBL] [Abstract][Full Text] [Related]
9. Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
Wolters F; van de Bovenkamp J; van den Bosch B; van den Brink S; Broeders M; Chung NH; Favié B; Goderski G; Kuijpers J; Overdevest I; Rahamat-Langedoen J; Wijsman L; Melchers WJ; Meijer A
J Clin Virol; 2020 Jul; 128():104426. PubMed ID: 32417674
[TBL] [Abstract][Full Text] [Related]
10. Sample collection and stabilization from saliva samples for SARS-CoV-2 detection by qPCR.
Biotechniques; 2020 Sep; 69(3):237. PubMed ID: 32929994
[No Abstract] [Full Text] [Related]
11. Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2.
Zhen W; Smith E; Manji R; Schron D; Berry GJ
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32332061
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2.
Chen JH; Yip CC; Poon RW; Chan KH; Cheng VC; Hung IF; Chan JF; Yuen KY; To KK
Emerg Microbes Infect; 2020 Dec; 9(1):1356-1359. PubMed ID: 32459137
[TBL] [Abstract][Full Text] [Related]
13. [Not Available].
Balavoine JF
Rev Med Suisse; 2020 Sep; 16(706):1726. PubMed ID: 32936565
[No Abstract] [Full Text] [Related]
14. Spit shines for easier coronavirus testing.
Service RF
Science; 2020 Aug; 369(6507):1041-1042. PubMed ID: 32855317
[No Abstract] [Full Text] [Related]
15. Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory.
Greene DN
J Appl Lab Med; 2020 Jul; 5(4):837-840. PubMed ID: 32761155
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a Point-of-Care Assay and a High-Complexity Assay for Detection of SARS-CoV-2 RNA.
Stevens B; Hogan CA; Sahoo MK; Huang C; Garamani N; Zehnder J; Kurzer J; Pinsky BA
J Appl Lab Med; 2020 Nov; 5(6):1307-1312. PubMed ID: 32761092
[TBL] [Abstract][Full Text] [Related]
17. Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays.
Lowe CF; Matic N; Ritchie G; Lawson T; Stefanovic A; Champagne S; Leung V; Romney MG
J Clin Virol; 2020 Jul; 128():104387. PubMed ID: 32380382
[TBL] [Abstract][Full Text] [Related]
18. Comparison of commercial assays and laboratory developed tests for detection of SARS-CoV-2.
Dust K; Hedley A; Nichol K; Stein D; Adam H; Karlowsky JA; Bullard J; Van Caeseele P; Alexander DC
J Virol Methods; 2020 Nov; 285():113970. PubMed ID: 32920028
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients.
Harrington A; Cox B; Snowdon J; Bakst J; Ley E; Grajales P; Maggiore J; Kahn S
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32327448
[No Abstract] [Full Text] [Related]
20. Recommendations for sample pooling on the Cepheid GeneXpert® system using the Cepheid Xpert® Xpress SARS-CoV-2 assay.
Becker MG; Taylor T; Kiazyk S; Cabiles DR; Meyers AFA; Sandstrom PA
PLoS One; 2020; 15(11):e0241959. PubMed ID: 33166373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
